Insider Trading & Ownership - Iterum Therapeutics plc (ITRM)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Iterum Therapeutics plc
Goto Prev, 0, 1, 2
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-01-26
Sale
2021-01-27
7:32 pm
Iterum Therapeutics plc ITRM Matthews Judith M.
Chief Financial Officer
33,868 $1.73 $58,592 28,632
(Direct)
View
2020-10-27
Purchase
2020-10-28
4:15 pm
Iterum Therapeutics plc ITRM Dunne Michael W.
Chief Scientific Officer
61,540 $0 $0 255,653
(Direct)
View
2020-09-30
Sale
2020-10-02
9:00 pm
Iterum Therapeutics plc ITRM Matthews Judith M.
Chief Financial Officer
56,130 $1.64 $92,053 0
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-01-25
Option Award
2021-01-27
7:32 pm
N/A
N/A
Iterum Therapeutics plc ITRM Matthews Judith M.
Chief Financial Officer
62,500 $0 28,632
(Direct)
View

Ownership
2020-12-02
4:30 pm
2021-01-21
2025-01-31
Iterum Therapeutics plc ITRM RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
10% Owner
0 $0 8,486,000
(Indirect)
View

Ownership
2020-11-23
5:01 pm
2021-01-21
2025-01-31
Iterum Therapeutics plc ITRM DENNER ALEXANDER J
Sarissa Capital Management LP
Sarissa Capital Offshore Master Fund LP
Sarissa Capital Catapult Fund LLC
Sarissa Capital Hawkeye Fund LP
Sarissa Capital Master Fund II LP
10% Owner
0 $0 19,292,768
(Indirect)
View
Goto Prev, 0, 1, 2